Tech Company Financing Transactions
AEGEA Funding Round
Alloy Ventures, BioMed Ventures and Covidien Ventures participated in a $36 million Series C funding round for AEGEA. The round was announced by the company on 5/4/2015.
Transaction Overview
Company Name
Announced On
5/4/2015
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series C
Investors
Proceeds Purpose
AEGEA will use this Series C capital to complete the submission of its PMA application to seek FDA approval to market its endometrial ablation procedure to treat abnormal uterine bleeding.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4055-A Campbell Ave.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
The AEGEA Vapor System utilizes water vapor to treat menorrhagia. Water vapor efficiently enables the body to naturally eliminate unwanted tissue.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/4/2015: Condition One venture capital transaction
Next: 5/4/2015: Real Matters venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs